Article
Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention.
Cancer discovery - 1 Jul 2013
Ingle James N, Liu Mohan, Wickerham D Lawrence, Schaid Daniel J, Wang Liewei, Mushiroda Taisei, Kubo Michiaki, Costantino Joseph P, Vogel Victor G, Paik Soonmyung, Goetz Matthew P, Ames Matthew M, Jenkins Gregory D, Batzler Anthony, Carlson Erin E, Flockhart David A, Wolmark Norman, Nakamura Yusuke, Weinshilboum Richard M
Abstract excerpt
The selective estrogen receptor modulators (SERM) tamoxifen and raloxifene can reduce the occurrence of breast cancer in high-risk women by 50%, but this U.S. Food and Drug Administration-approved prevention therapy is not often used. We attempted to identify genetic factors that contribute to va...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
